Low Dose Dasatinib Is Not As Active in a CML CP Cohort Enriched with Intermediate/High-Risk CML Chronic Phase: A Phase IIb Multi-Center Trial

Authors :: Aby Abraham
Hasmukh Jain
Jina Bhattacharyya
Dubashi Biswajit
Jayachandran PK
Dinesh Bhurani
Stalin Chowdary Bala
Suman Pramanik
Santhosh Devadas
Uday Prakash Kulkarni
Manju Sengar
Rayaz Ahmed
Thenmozhi Mani
Damodar Das
Parathan Karunakaran
Sadashivudu Gundeti
Rasmi Pallasseri
Nikhil Patkar
Manjunath Nookala
Smita Kayal
Poonkuzhali Balasubramanian
Source :: Blood. 140:6789-6790
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools